A Study to Evaluate the Contemporary Use of Ticagrelor in Coronary Artery Disease (CAD) in Patients Who Underwent Percutaneous Coronary Interventions (PCI)

Trial Profile

A Study to Evaluate the Contemporary Use of Ticagrelor in Coronary Artery Disease (CAD) in Patients Who Underwent Percutaneous Coronary Interventions (PCI)

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Dec 2015

At a glance

  • Drugs Ticagrelor (Primary) ; Clopidogrel; Prasugrel
  • Indications Coronary artery disease
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 29 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top